Intravitreal injection of bevacizumab for myopic choroidal neovascularization: 1-year follow-up

被引：0
|
作者：
P-C Wu
Y-J Chen
机构：
[1] Chang Gung Memorial Hospital-Kaohsiung Medical Center,Department of Ophthalmology
[2] Chang Gung University College of Medicine,undefined
来源：
Eye | 2009年 / 23卷
关键词：
avastin; bevacizumab; choroidal neovascularization; intravitreal injection; myopia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：2042 / 2045
页数：3
相关论文
共 50 条
  • [21] Intravitreal Bevacizumab for Nonsubfoveal Choroidal Neovascularization Associated With Angioid Streaks: 3-Year Follow-up Study
    Iacono, Pierluigi
    Parodi, Maurizio Battaglia
    La Spina, Carlo
    Bandello, Francesco
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 165 : 174 - 178
  • [22] Intravitreal injection of bevacizumab for naive myopic choroidal neovascularization: 19-month results
    De Bats, F.
    Grange, J. -D.
    Denis, P.
    Kodjikian, L.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2013, 36 (01): : 12 - 18
  • [23] Combined therapy with bevacizumab and photodynamic therapy for myopic choroidal neovascularization: A one-year follow-up controlled study
    Saviano, Sandro
    Piemarocchi, Rita
    Leon, Pia E.
    Mangogna, Alessandro
    Zanei, Andrea
    Sc, Fabiano Cavarzeran
    Tognetto, Daniele
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2014, 7 (02) : 335 - 339
  • [24] Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
    Jia-Kang Wang
    Tzu-Lun Huang
    Pei-Yao Chang
    Yen-Ting Chen
    Chin-Wei Chang
    Fang-Ting Chen
    Yung-Ray Hsu
    Yun-Ju Chen
    Scientific Reports, 8
  • [25] Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
    Wang, Jia-Kang
    Huang, Tzu-Lun
    Chang, Pei-Yao
    Chen, Yen-Ting
    Chang, Chin-Wei
    Chen, Fang-Ting
    Hsu, Yung-Ray
    Chen, Yun-Ju
    SCIENTIFIC REPORTS, 2018, 8
  • [26] Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization
    Mandal, S.
    Venkatesh, P.
    Sampangi, R.
    Garg, S.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (04) : 620 - 626
  • [27] INTRAVITREAL RANIBIZUMAB VERSUS BEVACIZUMAB FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION
    Iacono, Pierluigi
    Parodi, Maurizio Battaglia
    Papayannis, Alessandro
    Kontadakis, Stylianos
    Sheth, Saumil
    Cascavilla, Maria Lucia
    Bandello, Francesco
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (08): : 1539 - 1546
  • [28] Marginal crack after intravitreal bevacizumab for myopic choroidal neovascularization
    Sayanagi, Kaori
    Ikuno, Yasushi
    Soga, Kaori
    Wakabayashi, Taku
    Tano, Yasuo
    ACTA OPHTHALMOLOGICA, 2009, 87 (04) : 460 - 463
  • [29] Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study
    Chan, W-M
    Lai, T. Y. Y.
    Liu, D. T. L.
    Lam, D. S. C.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (02) : 150 - 154
  • [30] Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization - AII
    Nassaralla, Joao J.
    Nassaralla, Arthur A.
    Nassaralla, Joao J.
    Nassaralla, Belquiz A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
12345